QIAGEN powered by

Clinical Insights Portfolio

Rapid variant interpretation and reporting for germline and somatic clinical NGS tests

Empower your lab with two decades of insight 

To fulfill the timeliness of genomics-guided precision medicine, molecular diagnostic labs are challenged to rapidly analyze and interpret a growing number of genetic tests with the latest scientific evidence, drug approvals and treatment guidelines in an efficient, yet thorough, manner. 

QIAGEN offers expert-curated knowledge, software and services for next-generation sequencing (NGS) data interpretation and reporting to accelerate confident decision making at the point of care.

Human Gene Mutation Database (HGMD)

Solve more cases faster, with data you can trust using HGMD Professional, the de facto standard resource for identifying inherited disease-causing mutations​

QCI Interpret

Expand your clinical interpretation with expert-curated software for variant classification of any assay, covering any indication, on your sequencing platform

QCI Interpret One

Deliver oncologist-ready variant interpretation reports with QCI Interpret One, clinical decision support software with professional interpretation services.

QCI Precision Insights

Reimagine your clinical interpretation with same day, expert variant classification services tailored to your oncology panel

Clinical Analysis and Interpretation Services

Leverage the benefits of automation and expert support to improve test turnaround times and clinical reporting capabilities

QIAGEN Clinical Knowledge Base

Empower your clinical testing lab with the industry’s most expansive collection of up-to-date biological and clinical findings, delivering two decades of expert-curated evidence​

“Having access to the most comprehensive and up-to-date catalog of known mutations augments our existing variant classification expertise. This will allow us to continue to provide physicians and researchers with the best possible test interpretations, advancing LabCorp’s mission to improve health and improve lives.”

Marcia Eisenberg, PhD
Chief Scientific Officer for LabCorp Diagnostics

Hereditary Diseases

Empower clinicians and their patients to make critical and timely healthcare decisions with the latest publications and clinical evidence

Oncology

Provide oncologists with the best information needed to make timely, educated decisions about their patients’ cancer treatment plans

Pharmaceutical Development

From biomarker discovery and validation to trial design and label expansion, QIAGEN Real-World Insights (RWI) helps you bridge the gap between actionable insight and real-world action.